Straits Research Pvt Ltd
Electrocardiograph (ECG) Market Size is projected to reach USD 10.79 Billion by 2030, growing at a CAGR of 5.67%: Straits Research
09 août 2022 08h20 HE | Straits Research
New York, United States, Aug. 09, 2022 (GLOBE NEWSWIRE) -- North America is dominating the global electrocardiograph (ECG) market. In this regard, the United States has the largest market share. An...
InCarda Logo.png
InCarda Therapeutics Announces Enrollment of First Patient in Pivotal Phase 3 RESTORE-1 Trial of InRhythm™ for the Treatment of Paroxysmal Atrial Fibrillation
26 juil. 2022 07h00 HE | InCarda Therapeutics, Inc.
Single Pivotal Phase 3 Trial to Support Filing of New Drug Application Positive Phase 2 Efficacy and Safety Data for InRhythm Recently Highlighted as “Editor’s Pick” in Circulation: Arrhythmia...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute
21 juil. 2022 10h00 HE | BioSig Technologies, Inc.
Westport, CT, July 21, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
07 juil. 2022 08h30 HE | BioSig Technologies, Inc.
Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) -- OPRMC marks our first leasing agreement under new program Company also inks national master agreement with one of the largest U.S. healthcare...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Closing of Public Offering of Common Stock
29 juin 2022 17h45 HE | BioSig Technologies, Inc.
Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Pricing of Public Offering of Common Stock
24 juin 2022 09h30 HE | BioSig Technologies, Inc.
Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Proposed Public Offering of Common Stock
23 juin 2022 16h26 HE | BioSig Technologies, Inc.
Westport, CT, June 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic
22 juin 2022 08h00 HE | BioSig Technologies, Inc.
Westport, CT, June 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide
26 mai 2022 09h08 HE | BioSig Technologies, Inc.
Westport, CT, May 26, 2022 (GLOBE NEWSWIRE) -- Commercial pipeline to include 30 advanced leads at Medical Centers of Excellence Company’s development and operational infrastructure...
Bio-Sig-Logo-horiz.jpg
BioSig’s PURE EP™ System to be Featured During EPLive 2022
25 mai 2022 09h47 HE | BioSig Technologies, Inc.
Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering...